Regeneus (ASX:RGS) has been granted an ASX trading halt to consider and respond to recent media commentary in relation to its HiQCell® stem cell therapy.
This is specifically in response to the ABC 7.30 Report which aired on Monday, 6 October 2014.
The halt will last until the earlier of the announcement being made or the start of trading on Thursday, 9 October 2014.
